Antibody-drug conjugates as multimodal therapies against hard-to-treat cancers
{{output}}
Antibody-drug conjugates (ADCs) are rapidly emerging as an effective multimodal approach for the targeted delivery of cytotoxic small molecule to tumours with aberrantly overexpressed markers. Recent advances in antibody engineering and the emergence of highly... ...
